NeuroPace Statistics

Total Valuation

NeuroPace has a market cap or net worth of $573.42 million. The enterprise value is $583.20 million.

Market Cap	573.42M
Enterprise Value	583.20M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

NeuroPace has 33.95 million shares outstanding. The number of shares has increased by 12.35% in one year.

Current Share Class	33.95M
Shares Outstanding	33.95M
Shares Change (YoY)	+12.35%
Shares Change (QoQ)	+0.76%
Owned by Insiders (%)	3.74%
Owned by Institutions (%)	65.67%
Float	23.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.74
Forward PS	5.68
PB Ratio	29.80
P/TBV Ratio	30.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.28, with a Debt / Equity ratio of 3.72.

Current Ratio	5.28
Quick Ratio	4.25
Debt / Equity	3.72
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.19

Financial Efficiency

Return on equity (ROE) is -158.74% and return on invested capital (ROIC) is -11.93%.

Return on Equity (ROE)	-158.74%
Return on Assets (ROA)	-10.20%
Return on Invested Capital (ROIC)	-11.93%
Return on Capital Employed (ROCE)	-18.62%
Weighted Average Cost of Capital (WACC)	13.89%
Revenue Per Employee	$478,402
Profits Per Employee	-$102,703
Employee Count	209
Asset Turnover	1.00
Inventory Turnover	1.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +51.55% in the last 52 weeks. The beta is 1.88, so NeuroPace's price volatility has been higher than the market average.

Beta (5Y)	1.88
52-Week Price Change	+51.55%
50-Day Moving Average	14.61
200-Day Moving Average	12.95
Relative Strength Index (RSI)	66.44
Average Volume (20 Days)	157,919

Short Selling Information

The latest short interest is 916,811, so 2.70% of the outstanding shares have been sold short.

Short Interest	916,811
Short Previous Month	948,788
Short % of Shares Out	2.70%
Short % of Float	3.96%
Short Ratio (days to cover)	4.88

Income Statement

In the last 12 months, NeuroPace had revenue of $99.99 million and -$21.47 million in losses. Loss per share was -$0.66.

Revenue	99.99M
Gross Profit	77.22M
Operating Income	-16.34M
Pretax Income	-21.47M
Net Income	-21.47M
EBITDA	-16.10M
EBIT	-16.34M
Loss Per Share	-$0.66

Full Income Statement

Balance Sheet

The company has $61.06 million in cash and $70.84 million in debt, giving a net cash position of -$9.78 million or -$0.29 per share.

Cash & Cash Equivalents	61.06M
Total Debt	70.84M
Net Cash	-9.78M
Net Cash Per Share	-$0.29
Equity (Book Value)	19.03M
Book Value Per Share	0.57
Working Capital	76.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.01 million and capital expenditures -$332,000, giving a free cash flow of -$11.34 million.

Operating Cash Flow	-11.01M
Capital Expenditures	-332,000
Depreciation & Amortization	238,000
Net Borrowing	-2.07M
Free Cash Flow	-11.34M
FCF Per Share	-$0.33

Full Cash Flow Statement

Margins

Gross margin is 77.23%, with operating and profit margins of -16.34% and -21.47%.

Gross Margin	77.23%
Operating Margin	-16.34%
Pretax Margin	-21.47%
Profit Margin	-21.47%
EBITDA Margin	-16.10%
EBIT Margin	-16.34%
FCF Margin	n/a

Dividends & Yields

NeuroPace does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.35%
Shareholder Yield	-12.35%
Earnings Yield	-3.74%
FCF Yield	-1.98%

Analyst Forecast

The average price target for NeuroPace is $18.33, which is 8.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.33
Price Target Difference	8.53%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	15.18%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NeuroPace has an Altman Z-Score of -3.33 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.33
Piotroski F-Score	4